There is no single "best" time that applies universally to all patients, as the medication's pharmacokinetic profile allows for flexibility in dosing schedules
Outcomes were ascertained from routinely collected health records (e.g., registers, EHR, claims)
Liraglutide reduces CNS activation in response to visual food cues only after short-term treatment in patients with type 2 diabetes
Supports GLP-1 pathway naturally
Key Benefits and Uses Appetite Control: GLP-1 medications are effective in reducing appetite, making them a valuable tool for weight management
Its likely related to a finding that Camilleri and other researchers have repeatedly shown, which is that GLP-1 agonists slow down gastric emptying, the amount of time it takes the stomach to empty its contents into the small intestine (3)